News

Acute ischemic stroke is a leading global cause of death and disability. Intravenous thrombolysis was the first acute treatment developed for ischemic strokes. First with alteplase and now with ...
Our coverage of ACC 2025 in Chicago dominated our most-read stories, but other news on novel therapies made the list, too.
A Maryland man has filed a lawsuit against the manufacturers of Ozempic, alleging that his use of the drug led to him ...
An ophthalmologist urged her to rush to the emergency room for an MRI, where she was diagnosed with non-arteritic anterior ...
Discover phases of acute ischemic stroke care, from rapid recognition to long-term recovery strategies that neurologists use ...
In a large study of diabetes, heart failure, or chronic kidney disease patients on renin-angiotensin-aldosterone system (RAAS ...
Ozempic and similar weight loss drugs offer significant health benefits, including reduced heart disease risk and improved ...
A Howard County man is suing Novo Nordisk, alleging Ozempic caused him to go blind after using the drug to treat diabetes.
A Maryland man who took Ozempic and then became legally blind is suing the drug's manufacturer, arguing it had an obligation to warn patients that loss of sight could be a possible side effect. Todd ...
The lawsuit said about four months later, Engel was diagnosed with nonarteritic anterior ischemic optic neuropathy, or NAION, a condition in which a loss of blood flow to the optic nerve causes ...
Novo Nordisk faces a suit claiming it failed to warn users of Ozempic of the danger of blindness. The suit is brought by a Maryland man who developed non-arteritic anterior ischemic optic neuropathy ...